Intuitive Surgical, Inc. $ISRG Shares Acquired by Norris Perne & French LLP MI

Norris Perne & French LLP MI increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 118.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,082 shares of the medical equipment provider’s stock after acquiring an additional 1,128 shares during the quarter. Norris Perne & French LLP MI’s holdings in Intuitive Surgical were worth $847,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in ISRG. Main Street Group LTD acquired a new stake in Intuitive Surgical in the first quarter worth about $30,000. North Point Portfolio Managers Corp OH bought a new stake in Intuitive Surgical during the 3rd quarter worth about $27,000. Compass Wealth Management LLC bought a new stake in Intuitive Surgical during the 3rd quarter worth about $29,000. Evergreen Advisors LLC acquired a new position in Intuitive Surgical during the 1st quarter valued at about $35,000. Finally, Compass Financial Management LLC acquired a new position in Intuitive Surgical during the 2nd quarter valued at about $30,000. Institutional investors own 83.64% of the company’s stock.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a research note on Wednesday. Piper Sandler reissued an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Barclays reissued an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a research note on Wednesday. Truist Financial cut their price objective on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a report on Thursday, July 16th. Finally, TD Cowen reaffirmed a “buy” rating and issued a $485.00 price objective on shares of Intuitive Surgical in a research note on Monday, October 19th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $493.54.

Insiders Place Their Bets

In related news, Director Gary S. Guthart sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the transaction, the director owned 179 shares of the company’s stock, valued at approximately $70,364.90. This represents a 28.69% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock worth $4,891,989 over the last ninety days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Up 1.9%

Shares of Intuitive Surgical stock opened at $452.29 on Friday. The business has a fifty day simple moving average of $395.50 and a 200 day simple moving average of $409.13. The stock has a market cap of $156.78 billion, a PE ratio of 54.69, a price-to-earnings-growth ratio of 3.37 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.40 EPS. Analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.